Table 3.
Percent of patients adequately stage (≥16 lymph nodes) | P Value | |
---|---|---|
Male | 98/119 (82%) | 0.43 |
Female | 88/103 (85%) | |
Age<60 years | 72/83 (87%) | 0.29 |
Age≥60 years | 113/139 (81%) | |
BMI<30 kg/m2 | 145/169 (86%) | 0.03 |
BMI≥30 kg/m2 | 39/53 (74%) | |
Neoadjuvant chemotherapy | 99/111 (89%) | 0.02 |
No Neoadjuvant chemotherapy | 85/111 (77%) | |
Total/Subtotal Gastrectomy | 76/88 (86%) | 0.33 |
Distal Gastrectomy | 109/134 (81%) | |
D1 Lymphadenectomy | 10/16 (63%) | 0.03 |
D2 Lymphadenectomy | 175/206 (85%) | |
No EVD | 80/111 (72%) | <0.0001 |
EVD | 105/111 (95%) |
BMI: body mass index; EVD: ex vivo dissection